Skip to main content
Top

Drugs

Issue 4/2025

Content (11 Articles)

Emerging Immunotherapies for Disease Modification of Type 1 Diabetes

Timothy P. Foster, Brittany S. Bruggeman, Michael J. Haller

Update on the Treatment of Chronic Spontaneous Urticaria

Pavel Kolkhir, Jie Shen Fok, Emek Kocatürk, Philip H. Li, Tiia-Linda Okas, Joao Marcelino, Martin Metz

From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology

  • Open Access
  • Review Article

Bram C. Agema, Birgit C. P. Koch, Ron H. J. Mathijssen, Stijn L. W. Koolen

Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies

Germain Honvo, Laetitia Lengelé, Majed Alokail, Nasser Al-Daghri, Jean-Yves Reginster, Olivier Bruyère

Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)

Steven M. Silverstein, Francesco Oddone, Miriam Kolko, Christian K. Brinkmann, William C. Christie, Amanda K. Bicket, Petrus N. J. Gous, Jan Luebke, Jyotsna Maram, Ashley Nguyen, E. Randy Craven, Yongjia Pu, Jenny Jiao, Marina Bejanian, Michael R. Robinson, Gabriel Bercovich, Carolina Gentile, Simon Fabian Lerner, Anahi Lupinacci, Rodrigo Santos, Carlos Ignacio Zeolite, Nathan Kerr, Botio Anguelov, Veselin Daskalov, Dimitar Dzhelebov, Christina Grupcheva, Valentin Hristozov, Stanislava Ivanova, Aneta Misheva, Milen Penkov, Malina Topchiyska, Petar Yanev, Marek Fichtl, Christian Brinkmann, Jan Lubke, Marc Schargus, Christian van Oterendorp, Jasna Pavicic-Astalos, Carlo Cagini, Giovanni Milano, Vincenzo Scorcia, Enzo M. Vingolo, Tony Wells, Slawomir Cisiecki, Dorota Raczynska, Slawomir Teper, Dominik Zalewski, Petrus Gous, Nicolaas van Helsdingen, Pouya Alaghband, Rupert Bourne, Robert Cheeseman, Vincent Dubois, Marina Hopes, Gerassimos Lascaratos, Samantha Levin, Husam Ansari, Mahdi Basha, John Berdahl, Daniel Bettis, Amanda Bicket, Robert Blasberg, Delmar Caldwell, Louis Cantor, William Christie, Eran Duzman, John Elfervig, Richard Evans, Shailesh Gupta, Ron Gutmark, Jason Hendrix, Gary Jerkins, Adam Jorgensen, Jeffrey Kammer, Mahmoud Khaimi, Aarup Kubal, John Lind, Dwayne Logan, Elizabeth Martin, Sayoko Moroi, Marlene Moster, Andrew Moyes, Daniel Nolan, James Paauw, Abraham Park, Hemang Patel, Matthew Paul, Bernard Perez, Steven Sarkisian Jr, Bruce Segal, Manjool Shah, Steven Silverstein, Annette Sims, Mark Slabaugh, Dana Wallace, Gerald Walman, Thomas Walters, David Wirta

Olezarsen: First Approval

Yahiya Y. Syed

Revumenib: First Approval

Yahiya Y. Syed

Zenocutuzumab: First Approval

  • NSCLC
  • AdisInsight Report

Hannah A. Blair

Correction: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan

  • Open Access
  • Correction

Carlo Lombardi, Pasquale Comberiati, Erminia Ridolo, Marcello Cottini, Mona Rita Yacoub, Silvia Casagrande, Matteo Riccò, Marco Bottazzoli, Alvise Berti